VERO Biotech

Inhaled nitric-oxide generation platform (NITROSYL)

Privately held: no public share price · United States

Assets

(1 total)
1Total Assets
1Approved
0Phase 3 / Filed
0Phase 1–2 / Early
1Diseases
Showing 1 of 1 assets
Target & Modality
Approved
Soluble guanylyl cyclase (sGC)Other
Persistent Pulmonary Hypertension of the Newborn

Upcoming events

No upcoming trial completions or earnings dates on record for this company's assets.

Financial reports

No financial reports recorded.